Nurse Practitioner, Family · Las Vegas, NV
NPI
1568994531
Since 2017
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
7200 Cathedral Rock Dr Ste 170
Las Vegas, NV, 89128
Phone (702) 384-5101
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
668 services
Medicare patients, 2024
230
Average age 73
Drug cost, 2024
$2.6M
5,350 prescriptions
Company payments, 2025
$3,149
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Steven W Harker was code 99213 (office e&m - established), 195 times for 130 patients. In total Steven W Harker billed 668 services in 16 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-11-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 195 | 130 | $51.16 | $9,976 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 125 | 95 | $10.31 | $1,288 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 71 | 17 | $31.23 | $2,217 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 70 | 20 | $39.31 | $2,752 |
| 99212 Office E&M - Established | Office | 65 | 53 | $32.65 | $2,123 |
| 99214 Office E&M - Established | Office | 42 | 36 | $69.07 | $2,901 |
| 99203 Office E&M - New | Office | 41 | 41 | $64.67 | $2,651 |
| 94618 Pulmonary Function Testing | Office | 21 | 20 | $18.99 | $399 |
| 99202 Office E&M - New | Office | 13 | 13 | $32.69 | $425 |
By year: 2022 $25K for 791 services; 2023 $29K for 616 services; 2024 $27K for 668 services.
Medicare prescription drug claims, 2024
In 2024, the drug Steven W Harker prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 1,082 prescriptions and refills. In total Steven W Harker wrote 5,350 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 1,082 | 1,247 | 437 | $33K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 718 | 1,069 | 156 | $682K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 635 | 863 | 174 | $543K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 328 | 582 | 109 | $64K |
| Montelukast Sodium Generic | 319 | 774 | 112 | $2,315 |
| Symbicort Budesonide/Formoterol Fumarate | 292 | 387 | 78 | $88K |
| Breo Ellipta Fluticasone/Vilanterol | 223 | 289 | 58 | $113K |
| Wixela Inhub Fluticasone Propion/Salmeterol | 181 | 196 | 45 | $20K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 180 | 266 | 40 | $125K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 173 | 185 | 46 | $85K |
| Advair Hfa Fluticasone Propion/Salmeterol | 131 | 160 | 32 | $51K |
| Spiriva Respimat Tiotropium Bromide | 116 | 195 | 32 | $98K |
| Prednisone Generic | 115 | 148 | 80 | $493 |
| Ventolin Hfa Albuterol Sulfate | 94 | 106 | 53 | $6,617 |
| Fluticasone Propionate Generic | 77 | 160 | 34 | $643 |
Brand drugs: 3,733 claims; generic drugs: 1,617 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Steven W Harker $3,149 ($3,149 in general payments such as food, travel and fees) from 15 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $996.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 27 | $996 |
| Verona Pharma, Inc. VRNA | 12 | $823 |
| Genzyme Corporation SNY | 4 | $329 |
| GlaxoSmithKline, LLC. GSK | 13 | $224 |
| Electromed, Inc. ELMD | 9 | $190 |
| Gilead Sciences, Inc. GILD | 1 | $130 |
| Exact Sciences Corporation EXAS | 1 | $116 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $75.65 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $61.75 |
| Amgen Inc. AMGN | 2 | $54.66 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.